| Abstrak/Abstract |
To ensure that the quality of pharmaceutical products is maintained throughout the
distribution chain, it is necessary to implement Good Distribution Practices at distribution
facilities that distribute pharmaceutical products. This literature review explores the
evaluation of Good Drug Distribution (GDP) or CDOB guideline practices in pharmaceutical
product distribution facilities engaged in the public and private sectors in Indonesia. The
literature review method used the Preferred Reporting Items for Systematic Reviews and
Meta-Analyses (PRISMA) protocol. Articles were searched using the Google Scholar database
and restricted to those related to GDP published from 2018 to 2022. The literature was
reviewed using questions to assess studies organized by Population, Exposure, and Outcome
(PEO) criteria. Articles obtained were then identified, screened, eligibility, then selected based
on inclusion and exclusion criteria resulting in 19 pieces that will be extracted data. Of the
19 articles, the study was conducted in several pharmaceutical distribution facilities such as
the Health Office, Puskesmas, Hospitals, Pharmacies, and Pharmaceutical Wholesalers
spread across Indonesia. All articles used descriptive methods to show the conformity of
implementing Good Distribution Practices guidelines. Some studies still do not use the latest
regulation, namely the Food and Drug Administration Regulation Number 6 of 2020
concerning Amendments to BPOM Regulation Number 9 of 2019 concerning Technical
Guidelines for Good Distribution Methods. The suggestions that can be made include the
need for studies related to the evaluation of Good Distribution Practices of pharmaceutical
distribution facilities in the public or government sector and studies on distribution facilities
in Eastern Indonesia |
